Pediatric cancer research could get a $3 million yearly funding boost under a bill Iowa lawmakers advanced Wednesday.

The FDA has extended the deadline to review Orca-T for the treatment of myelodsyplastic syndromes and acute leukemias with a ...

The integrity of DNA and RNA is essential for every cell. DNA contains the genetic information for proteins, while RNA serves ...

“I did not hesitate even for a moment,” Kaedi Cecala’s donor, Karol Zwierzinski, tells PEOPLE ...

Trial advancing with ongoing safety and pharmacologic evaluation and planned expansion into MDS and MFSOUTH SAN FRANCISCO, Calif., March 30, ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Datopotamab deruxtecan showed a 5.0-month OS improvement versus chemotherapy in first-line unresectable/metastatic TNBC ...

Trial advancing with ongoing safety and pharmacologic evaluation and planned expansion into MDS and MF SOUTH SAN FRANCISCO, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc.

New PDUFA Target Action Date of July 6, 2026 allows FDA additional time to complete its reviewMENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company committed to ...

Shareholders approve acquisition of Aptose by Hanmi Pharmaceutical in “Go Private” transaction TUS+VEN+AZA triplet frontline therapy continues to ...